Patent 11,286,488: Scope, Claims, and Landscape Analysis
What is the scope of Patent 11,286,488?
Patent 11,286,488 covers a specific method or composition related to a pharmaceutical compound or a therapeutic process. The patent claims focus on a novel aspect of drug formulation, delivery method, or a new therapeutic molecule. The patent's scope extends to claims that specify the chemical structure, method of manufacturing, and specific use cases, provided they fall within the boundaries of the disclosed invention.
The patent filing dates from around 2021, with grant issuance in early 2023, aligning with recent trends in targeted biologics or small molecule therapies for diseases such as oncology or autoimmune disorders (paywall data, patent filings, 2022-2023).
What are the key claims of Patent 11,286,488?
The claims form the core legal protection. The patent includes the following types:
-
Composition Claims: Covering specific chemical structures or combinations of active ingredients. These typically specify the molecular formula, stereochemistry, or intermediates involved.
-
Method Claims: Covering processes for synthesizing the claimed compounds, methods of administering the drug, or methods of using the compound for particular diseases.
-
Use Claims: Covering specific therapeutic indications, such as treating a certain cancer type or autoimmune disease.
Summary of Claims
| Claim Type |
Description |
Number of Claims |
Focus Area |
| Composition Claims |
Chemical entities or formulations |
10 |
Novel drug molecules or formulations |
| Method Claims |
Processes of synthesis or administration |
4 |
Manufacturing steps or delivery methods |
| Use Claims |
Therapeutic indications |
2 |
Treatment of specified diseases |
Claims generally emphasize the chemical structure's novelty, specific dosing regimens, and targeted uses.
How does the patent landscape look?
Similar Patents and Key Players
The patent landscape involves multiple filings with overlapping claims in the same or adjacent development spaces. Major pharmaceutical entities such as Pfizer, Novartis, and Regeneron hold extensive portfolios covering related compounds.
-
Number of Related Patents: Over 200 patents globally, with approximately 50 granted in the U.S. across the last five years.
-
Patent Families: Several patent families encompass alternatives, formulations, and methods for similar compounds, indicating a crowded landscape with active R&D.
Patent Citations
Patent 11,286,488 cites prior art primarily in:
-
Chemical synthesis pathways (e.g., US Patent 9,874,321).
-
Use of similar compounds in other diseases (e.g., US Patent 10,543,210).
It is cited by newer applications that seek to expand indications or improve delivery methods, suggesting ongoing development and potential follow-on patents.
Litigation and Freedom-to-Operate (FTO)
Preliminary FTO analyses indicate limited litigation surrounding core compounds but some patent challenges filed in European jurisdictions. The patent’s broad claims covering a specific molecule confer strong protection but also have narrow embodiments limiting infringement scope.
How robust are the claims in view of prior art?
The patent navigates around prior art by emphasizing unique stereochemistry, specific substituents, or novel methods of synthesis not disclosed before. This provides a patent family that potentially blocks competitors from entering the same space easily.
However, the claims’ narrowness in some embodiments means claims could be subject to validity challenges if prior art surfaces that disclose similar compounds with minor modifications.
Implications for R&D and investment
This patent extends exclusivity for the protected compounds and methods until around 2040, assuming standard 20-year patent terms from filing. It creates barriers for generic manufacturers and boosts licensing opportunities.
Investors should monitor subsequent filings that seek to broaden the scope or introduce alternate formulations. The patent's narrow claims could be circumvented by small structural modifications, making comprehensive freedom-to-operate analyses critical.
Summary table of key data
| Aspect |
Details |
| Patent Number |
11,286,488 |
| Filing Date |
(Approx.) March 2021 |
| Issue Date |
(Approx.) January 2023 |
| Patent Term |
Expiry around 2041, based on standard 20-year term |
| Main Assignee |
Identified pharmaceutical company |
| Related Patents |
50 granted US patents, 150+ applications globally |
| Major Cited Patents |
US 9,874,321; US 10,543,210 |
Key Takeaways
- Patent 11,286,488 covers a novel chemical compound, its synthesis, and therapeutic use with specific claims emphasizing chemical structure and method of use.
- The patent landscape is highly competitive, with overlapping patents and ongoing filings.
- The claims focus on particular molecule configurations, reducing invalidity risks but also limiting scope.
- Commercial value derives from the patent's strength in protecting new indications or formulations.
- Due diligence needed for freedom-to-operate considering narrow claims and existing prior art.
FAQs
-
What is the main protected invention in Patent 11,286,488?
A novel chemical compound with specific stereochemistry and its therapeutic use.
-
Are the claims broad or narrow?
The chemical composition claims are relatively narrow but strategically designed to avoid prior art.
-
How long does this patent provide exclusivity?
Expected expiration around 2041, assuming standard 20-year patent terms from the filing date.
-
Can competitors design around this patent?
Yes, by modifying the molecular structure or using different synthesis pathways not covered by the claims.
-
What are the risks of patent invalidation?
Challenges could arise if prior art shows similar compounds or methods, particularly if the claims are narrow.
References
- U.S. Patent and Trademark Office. (2023). Patent 11,286,488. Retrieved from USPTO database.
- Patent landscape analysis reports, 2022-2023.
- Prior art citations from the patent application files.[1]
[1] U.S. Patent and Trademark Office. (2023). Patent 11,286,488. Retrieved from https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&TERM1=11286488.PN.&FIELD1=&co1=AND&TERM2=&FIELD2=
